Moedas / BMRN
BMRN: BioMarin Pharmaceutical Inc
55.91
USD
1.41
(2.59%)
A taxa do BMRN para hoje mudou para 2.59%. Paralelamente, o preço mais baixo no mercado atingiu 54.20 e o mais alto foi 55.94.
Veja a dinâmica do par de moedas BioMarin Pharmaceutical Inc. As cotações em tempo real ajudam a reagir rapidamente aos movimentos do mercado. Ao alternar entre os diferentes períodos de tempo, você pode monitorar tendências e movimentos de preços por minuto, hora, dia, semana ou mês. Use estas informações para prever os movimentos do mercado e tomar decisões de negociação informadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BMRN Notícias
- Biomarin at Morgan Stanley Conference: Strategic Growth and Innovation
- Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
- PTC Therapeutics To Challenge BioMarin's Metabolic Disorder Treatment - BioMarin Pharmaceutical (NASDAQ:BMRN)
- This Duolingo Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Bullish (NYSE:BLSH), BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin’s PKU drug shows nearly 50% blood Phe reduction in teens
- BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
- BioMarin Pharmaceutical Inc. (BMRN) Presents at Cantor Global Healthcare Conference 2025
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
- BioMarin stock rating reiterated at Outperform by Oppenheimer on Voxzogo strength
- BioMarin stock price target raised to $95 by Bernstein following Inozyme acquisition
- BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
- Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
- Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
- BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030 - BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
- 3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts - TipRanks.com
- BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Call Transcript
- BioMarin (BMRN) Q2 Revenue Jumps 16%
- BioMarin (BMRN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- BioMarin (BMRN) Q2 2025 Earnings Call Transcript
- Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises
- BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
- After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
Faixa diária
54.20
55.94
Faixa anual
52.94
73.51
- Fechamento anterior
- 54.50
- Open
- 54.46
- Bid
- 55.91
- Ask
- 56.21
- Low
- 54.20
- High
- 55.94
- Volume
- 4.773 K
- Mudança diária
- 2.59%
- Mudança mensal
- -4.26%
- Mudança de 6 meses
- -20.36%
- Mudança anual
- -20.50%
11 setembro, quinta-feira
08:00
ALL
- Atu.
- Projeç.
- Prév.
11:00
ALL
- Atu.
- Projeç.
- Prév.
12:30
USD
- Atu.
- Projeç.
- 0.2%
- Prév.
- 0.2%
12:30
USD
- Atu.
- Projeç.
- 0.3%
- Prév.
- 0.3%
12:30
USD
- Atu.
- Projeç.
- 2.9%
- Prév.
- 2.7%
12:30
USD
- Atu.
- Projeç.
- 3.3%
- Prév.
- 3.1%
12:30
USD
- Atu.
- Projeç.
- Prév.
- 0.2%
12:30
USD
- Atu.
- Projeç.
- 322.956
- Prév.
- 322.132
12:30
USD
- Atu.
- 263 mil
- Projeç.
- 235 mil
- Prév.
- 236 mil
12:30
USD
- Atu.
- 1.939 milh
- Projeç.
- 1.923 milh
- Prév.
- 1.939 milh
17:00
USD
- Atu.
- 4.651%
- Projeç.
- Prév.
- 4.813%
18:00
USD
- Atu.
- $-344.8 bilh
- Projeç.
- $-283.5 bilh
- Prév.
- $-291.1 bilh